| 1 |
28024166 | East Asian perspective on the interaction between proton pump inhibitors and clopidogrel. | 2017 Jun |
1 |
| 2 |
29018343 | Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects. | 2017 |
1 |
| 3 |
19067473 | Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies. | 2009 |
1 |
| 4 |
17190370 | Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus. | 2006 Dec |
2 |
| 5 |
15788366 | Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro. | 2005 Jan |
1 |
| 6 |
15963095 | Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine. | 2005 Jul |
1 |
| 7 |
15448955 | Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes. | 2004 Nov |
1 |
| 8 |
12152007 | Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19. | 2002 Jul |
1 |